{"id":43648,"date":"2025-07-16T16:24:10","date_gmt":"2025-07-16T10:54:10","guid":{"rendered":"https:\/\/financialtelegraph.in\/index.php\/2025\/07\/16\/homeopathys-triumph-in-itp-treatment-offers-new-hope-for-blood-disorders\/"},"modified":"2025-07-16T16:24:10","modified_gmt":"2025-07-16T10:54:10","slug":"homeopathys-triumph-in-itp-treatment-offers-new-hope-for-blood-disorders","status":"publish","type":"post","link":"https:\/\/financialtelegraph.in\/index.php\/2025\/07\/16\/homeopathys-triumph-in-itp-treatment-offers-new-hope-for-blood-disorders\/","title":{"rendered":"Homeopathy\u2019s Triumph in ITP Treatment Offers New Hope for Blood Disorders"},"content":{"rendered":"
\n

\"Homeopathy\"<\/p>\n

Indore (Madhya Pradesh) [India], July 16:<\/strong> <\/span>A groundbreaking advancement in the treatment of blood disorders has emerged from\u00a0Advanced Homoeo Health Center and Homeopathic Medical Research Pvt. Ltd.<\/strong>, located at Geeta Bhawan, Indore. Under the leadership of\u00a0Dr. A.K. Dwivedi<\/strong>, a senior homeopathic physician, member of the Scientific Advisory Board (CCRH), Ministry of AYUSH, Government of India, and Executive Council Member at Devi Ahilya Vishwavidyalaya, Indore, a revolutionary approach in homeopathy is offering renewed hope for patients battling rare and life-threatening conditions like\u00a0Immune Thrombocytopenia (ITP)<\/strong>,\u00a0Aplastic Anemia<\/strong>, and\u00a0Myelodysplastic Syndrome (MDS)<\/strong>.<\/p>\n

A compelling success story has captured medical attention:\u00a07-year-old Ayushmann Singh<\/strong>\u00a0from Azamgarh, Uttar Pradesh, was diagnosed with severe ITP, with platelet levels critically low at just 8,000. After undergoing\u00a012 months of continuous and evidence-based homeopathic treatment using advanced 50 millesimal potency<\/strong>, Ayushmann\u2019s platelet count dramatically increased to\u00a02.3 lakhs<\/strong>, allowing him to return to a normal life\u2014attending school, playing with friends, and enjoying a healthy childhood once again.<\/p>\n

\u201cThis is more than a medical case\u2014it is a message of hope,\u201d said Dr. Dwivedi. \u201cIn immune thrombocytopenia, the body\u2019s own immune system destroys its platelets. Our specialized approach in homeopathy offers not only symptom relief but addresses the patient\u2019s complete physical, emotional, and mental wellbeing.\u201d<\/p>\n

Conventional treatments for ITP, such as long-term steroid use, immunoglobulins, or bone marrow transplants, often come with limited efficacy and severe side effects. In contrast, Dr. Dwivedi\u2019s patient-centered and scientifically grounded homeopathic protocols present a\u00a0low-risk and sustainable alternative<\/strong>, especially in chronic and difficult-to-treat conditions.<\/p>\n

Widely acclaimed as\u00a0\u201cHope for the Bloodless\u201d<\/strong>, Dr. Dwivedi is known for his pioneering work in treating aplastic anemia and promoting anemia awareness through homeopathy. His efforts are inspiring growing interest in integrating homeopathy into mainstream healthcare conversations, especially for conditions with limited conventional solutions.<\/p>\n

The case of young Ayushmann has become a\u00a0beacon for families seeking effective and gentle treatment paths<\/strong>, underscoring the potential of homeopathy not as an alternative, but as a serious and scientifically validated medical choice.<\/p>\n

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.<\/em><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Indore (Madhya Pradesh) [India], July 16: A groundbreaking advancement in the treatment of blood disorders has emerged from\u00a0Advanced Homoeo Health Center and Homeopathic Medical Research Pvt. Ltd., located at Geeta … Read More<\/a><\/p>\n","protected":false},"author":1,"featured_media":43649,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[448],"class_list":["post-43648","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","tag-business","entry"],"_links":{"self":[{"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/posts\/43648","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/comments?post=43648"}],"version-history":[{"count":0,"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/posts\/43648\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/media\/43649"}],"wp:attachment":[{"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/media?parent=43648"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/categories?post=43648"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/financialtelegraph.in\/index.php\/wp-json\/wp\/v2\/tags?post=43648"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}